Maria Amaya MD PhD
banner
mariaamaya27.bsky.social
Maria Amaya MD PhD
@mariaamaya27.bsky.social
Physician Scientist, University of Colorado | MDS, AML |
Pinned
Took me long but better late than never! This is our lab website and this Thanksgiving weekend I am grateful for everyone in the lab, they make science so fun!

ladybug-triceratops-dpm6.squarespace.com
THE AMAYA LAB
ladybug-triceratops-dpm6.squarespace.com
Day 1 of ASH ✅
Excited to see more friends over the weekend!
December 6, 2025 at 12:02 AM
So proud of Dr. Cassandra Duarte for publishing this important study with the help of the Flatiron database!

“Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia”

haematologica.org/newsletter/v...
Early View | Haematologica
haematologica.org
September 20, 2025 at 3:42 AM
Reposted by Maria Amaya MD PhD
A US Senate committee endorsed maintaining the NIH's structure and increasing its funding by US$400 million, or about 1%

go.nature.com/4mg193S
‘Congress has your back’: US senators tell scientists they want to protect NIH budget
Senate budget bill includes small increase for the health-research agency — but faces a long road before being signed into law.
go.nature.com
August 1, 2025 at 1:14 PM
Reposted by Maria Amaya MD PhD
Congrats to my friend James DeGregori and his partner Mercedes Rincon and everyone involved on this beautiful study!
nature.com Nature @nature.com · Jul 30
Hidden in the lungs of some breast cancer survivors are tumour cells that can remain dormant for decades — until they one day trigger a relapse

go.nature.com/41iIdJR
‘Sleeping’ cancer cells in the lungs can be roused by COVID and flu
Inflammation from the respiratory infections seems to be the culprit, study in mice finds.
go.nature.com
July 31, 2025 at 6:23 AM
Reposted by Maria Amaya MD PhD
May the odds be ever in your favor.
4% payline at the NCI.

www.cancer.gov/grants-train...
Funding Policy - Research Grants
NCI funding policy for research project grant (RPG) awards reflects the funding goals of the institute, NIH, and HHS.
www.cancer.gov
July 24, 2025 at 2:11 AM
Reposted by Maria Amaya MD PhD
Orientation week is over and we are excited to have the new first years on rotation with us!
July 9, 2025 at 3:26 PM
Outcomes of oral azacitidine and venetoclax in newly diagnosed AML. High responses in TP53 mut patients. www.vjhemonc.com/video/wmkfly...
Outcomes with an all-oral regimen of CC-486 and venetoclax in patients with newly diagnosed AML
Maria Amaya, MD, PhD, University of Colorado Anschutz Medical Campus, Aurora, CO, presents the results from a clinical study (NCT05287568)...
www.vjhemonc.com
June 18, 2025 at 3:59 PM
Come check out our poster tonight! EHA2025
June 14, 2025 at 8:50 AM
We made it!
June 12, 2025 at 8:58 AM
Reposted by Maria Amaya MD PhD
Congratulations to Maria Amaya, MD, PhD, Assistant Professor of Medicine-Hematology (and CU HemeOnc Fellowship alumni) on being selected as one of the 2025 Translational Research Scholars. Each scholar receives research support over four years. #CUAnschutz #CUCancer
June 10, 2025 at 5:43 PM
Reposted by Maria Amaya MD PhD
Four CU Cancer Center members have been tapped to serve as ambassadors for its four main scientific and clinical research programs ⬇️
‘Building Bridges’: The CU Cancer Center Names Four Program Liaisons
Four CU Cancer Center members have been tapped to serve as ambassadors for its four main scientific and clinical research programs.
news.cuanschutz.edu
May 27, 2025 at 4:04 PM
Reposted by Maria Amaya MD PhD
An international study led by @cucancercenter.bsky.social
has uncovered why a widely used treatment for acute myeloid #leukemia doesn’t work for everyone. The findings could help doctors better match patients with the therapies most likely to work for them. 💡
New Study Reveals Why Common Leukemia Treatments Fail in Some Patients
An international study led by the CU Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn’t work for everyone.
news.cuanschutz.edu
May 22, 2025 at 9:20 PM
Reposted by Maria Amaya MD PhD
The crazy thing about firing all of these federal employees is that they tend to be underpaid, super hardworking, in it for the right reasons, idealistic people who could’ve worked in industry or pharma and made way more money but they truly believed in the mission and the good they were doing.
April 2, 2025 at 1:11 AM
Reposted by Maria Amaya MD PhD
Unfortunately was not able to travel to EBMT but our poster can still be viewed virtually! We report on the first 7 #VEXAS patients who underwent allo-HCT on our prospective phase II trial. High rates of #GVHD and other inflammatory complications noted. @ Bhavisha Patel
March 31, 2025 at 1:13 PM
jamanetwork.com/journals/jam...

If part of the RIF is to let term contracts expire, they will completely decimate VA research in a matter of months, and researchers will be terminated with no severance.
Veterans Affairs Research Under Threat
This Viewpoint discusses the critical importance of continued funding for the intramural research program in the Department of Veterans Affairs.
jamanetwork.com
March 30, 2025 at 1:09 AM
All amazing women!
As Women's History Month comes to a close, we celebrate the incredible women on our primary faculty and their invaluable contributions to the pharmacology field. Their dedication to research, mentorship and innovation continues to shape the future of science and medicine. #WomeninSTEM #CUAnschutz
March 26, 2025 at 5:30 PM
Good news for the week! (This Venezuelan federal worker is still making it work 😉)

1. We published our small retrospective study in CCUS vs tCCUS
www.tandfonline.com/doi/full/10....

2. Makenna from the lab presented her work to legislators and the public at the State capitol!
March 13, 2025 at 11:11 PM
It’s been tough, not going to lie, but today we got a paper accepted and one of my PRAs’ visas got renewed and we will take any victories we can get! ❤️👩🏻‍🔬👩🏻‍🔬
March 7, 2025 at 2:36 AM
Reposted by Maria Amaya MD PhD
CU Cancer Center's Deputy Associate Director of the Office of Engagement, Access, and Success, Curtis Henry, PhD, shares his thoughts with 9 News about the @acscan.bsky.social report that cancer is the second-leading cause of death for Black people ⬇️
www.9news.com/video/news/h...
March 5, 2025 at 1:04 AM
If they fire staff that supports research, physicians and investigators will also be forced to leave…
1400 more firings at Veterans Affairs:

"Officials said specifically that Veterans Crisis Line responders were not affected by the dismissals. But workers within the department said that support staff for the crisis line were among the workers let go..."

www.militarytimes.com/veterans/202...
VA fires 1,400 more staffers in second round of workforce reductions
About 2,500 VA workers have been forced out of their jobs in the last few weeks.
www.militarytimes.com
February 25, 2025 at 11:03 PM
Reposted by Maria Amaya MD PhD
“There’s going to be a missing age class of researchers that will reverberate for years.” scim.ag/3ERRLDo
U.S. early-career researchers struggling amid chaos
Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard
scim.ag
February 24, 2025 at 2:59 PM
Reposted by Maria Amaya MD PhD
CU Cancer Center member Manali Kamdar, MD, started to think about pivoting from her dream of being a dancer to a different profession after receiving care for a spinal injury. Now she is a highly recognized leading lymphoma researcher ⬇️
Dancer to Doctor: Dreams Fuel Top Lymphoma Researcher’s Success
Manali Kamdar, MD, has transformed lymphoma care with groundbreaking chemo-free therapies, leading to improved patient outcomes and FDA-approved therapies.
bit.ly
February 11, 2025 at 3:00 PM
Reposted by Maria Amaya MD PhD
There’s no argument that should reassure anyone enough to go back to business as usual, because none of these actions are happening in isolation. The war on US science won’t end with a court order on indirects.
February 9, 2025 at 3:10 PM
Reposted by Maria Amaya MD PhD
I believe that most of our society values science and scientists. We need to continue to communicate our findings and value to the public and advocate for increased research funding, especially for young investigators->they are the future.
February 8, 2025 at 9:24 PM
Excited to share this commentary on a very interesting clinical trial for AML ashpublications.org/blood/articl...
@bloodjournal.bsky.social
A novel therapy with a rational design for AML
In this issue of Blood, Liu et al1 report the results of a phase 1 clinical trial using pegcrisantaspase (PegC) in combination with venetoclax in relapsed
ashpublications.org
February 3, 2025 at 4:45 PM